Clarivate Plc (CLVT) Stock: A SWOT Analysis

Company’s 36-month beta value is 1.14.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 4 as “overweight,” 5 as “hold,” and 1 as “sell.”

The public float for CLVT is 416.53M, and currently, short sellers hold a 8.40% ratio of that floaft. The average trading volume of CLVT on November 18, 2024 was 4.29M shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

CLVT) stock’s latest price update

Clarivate Plc (NYSE: CLVT)’s stock price has gone rise by 3.85 in comparison to its previous close of 4.33, however, the company has experienced a -2.04% decrease in its stock price over the last five trading days. prnewswire.com reported 2024-11-18 that New report analyses Mainland China’s transformation into a global biopharma powerhouse, with key insights for international stakeholders LONDON, Nov. 18, 2024 /PRNewswire/ — Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, in partnership with Healthcare Executive, published by the China Pharmaceutical Enterprises Association, today announced the release of a new report, A Decade of Innovation, A Decade to Come. Over the past decade, Mainland China’s biopharmaceutical sector has rapidly advanced to become a global leader in innovation, ranking among the top three for initial drug launches.

CLVT’s Market Performance

CLVT’s stock has fallen by -2.04% in the past week, with a monthly drop of -32.89% and a quarterly drop of -30.61%. The volatility ratio for the week is 5.59% while the volatility levels for the last 30 days are 4.41% for Clarivate Plc The simple moving average for the past 20 days is -20.58% for CLVT’s stock, with a -32.14% simple moving average for the past 200 days.

Analysts’ Opinion of CLVT

Wells Fargo, on the other hand, stated in their research note that they expect to see CLVT reach a price target of $8. The rating they have provided for CLVT stocks is “Underweight” according to the report published on December 15th, 2023.

Jefferies gave a rating of “Buy” to CLVT, setting the target price at $8.50 in the report published on October 16th of the previous year.

CLVT Trading at -28.57% from the 50-Day Moving Average

After a stumble in the market that brought CLVT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -53.19% of loss for the given period.

Volatility was left at 4.41%, however, over the last 30 days, the volatility rate increased by 5.59%, as shares sank -32.61% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -32.71% lower at present.

During the last 5 trading sessions, CLVT fell by -2.51%, which changed the moving average for the period of 200-days by -51.83% in comparison to the 20-day moving average, which settled at $5.66. In addition, Clarivate Plc saw -51.44% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at CLVT starting from Veinstein Bar, who sale 60,000 shares at the price of $7.00 back on Oct 15 ’24. After this action, Veinstein Bar now owns 916,583 shares of Clarivate Plc, valued at $420,000 using the latest closing price.

BAR VEINSTEIN, the Officer of Clarivate Plc, proposed sale 60,000 shares at $7.00 during a trade that took place back on Oct 15 ’24, which means that BAR VEINSTEIN is holding shares at $420,000 based on the most recent closing price.

Stock Fundamentals for CLVT

Current profitability levels for the company are sitting at:

  • 0.07 for the present operating margin
  • 0.52 for the gross margin

The net margin for Clarivate Plc stands at -0.5. The total capital return value is set at 0.02. Equity return is now at value -21.14, with -10.13 for asset returns.

Based on Clarivate Plc (CLVT), the company’s capital structure generated 0.46 points at debt to capital in total, while cash flow to debt ratio is standing at 0.15. The debt to equity ratio resting at 0.84. The interest coverage ratio of the stock is 0.64.

Currently, EBITDA for the company is -85.9 million with net debt to EBITDA at -16.58. When we switch over and look at the enterprise to sales, we see a ratio of 2.92. The receivables turnover for the company is 3.34for trailing twelve months and the total asset turnover is 0.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.88.

Conclusion

In a nutshell, Clarivate Plc (CLVT) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts